Big Pharma's Biggest Winners
In the following video, Fool contributor Maxxwell Chatsko talks with health care analyst Max Macaluso and recaps the latest earnings results from the pharmaceutical industry. These companies each saw healthy gains in operating results and have big upcoming launches, such as Invokana from Johnson & Johnson and Eliquis from Pfizer . Nonetheless, investors will need to keep a long-term focus when viewing these complex pharmaceutical giants.
While you can certainly make huge gains in pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article Big Pharma's Biggest Winners originally appeared on Fool.com.Fool contributor Maxx Chatsko and Max Macaluso, Ph.D. have no position in any stocks mentioned. Check out Maxwell's personal portfolio, his CAPS page, or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies.The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.